MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Allogene Therapeutics, Inc. Common Stock

ALLO

#2380
Allogene Therapeutics, Inc. Common Stock
2.78
+4.12%
Sector:
Básica:
Profit Currency:
Rango diario
2.78
2.78
Rango anual
0.86
2.73
Cambio diario
+4.12%
Monthly Change
+80.52%
6 month change
+135.59%
Cambio anual
+44.79%
Cierres anteriores
2.67
Open
2.78
Bid
Ask
Low
2.78
High
2.78
Volumen
104
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. ALLO
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Zacks Zacks
ANIP ALLO CSTL VTRS
anteayer, 16:44
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
Zacks Zacks
ANIP ADMA ALLO CSTL
anteayer, 15:54
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Seeking Alpha Seeking Alpha
ALLO
2026.02.18
Allogene Therapeutics, Inc. (ALLO) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Investing Investing
GIS ORCL AAPL LUV GPC
2026.02.17
Apple, General Electric among market cap stock movers on Tuesday
Investing Investing
CLLS ALLO
2026.02.17
Jefferies asume cobertura de acciones de Cellectis con calificación de Compra
Investing Investing
CLLS ALLO
2026.02.17
Jefferies inicia cobertura de Cellectis con calificación de Compra
Investing Investing
CLLS ALLO
2026.02.17
Jefferies assumes coverage on Cellectis stock with Buy rating
Zacks Zacks
ALLO MCK
2026.02.11
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
Zacks Zacks
PFE MRK LLY ABBV RCUS
2026.02.05
Rapid Innovation is Reshaping Oncology: Stocks in Focus
Investing Investing
ALLO
2026.02.05
Vicepresidente ejecutivo de Allogene vende acciones por 63.189 dólares y obtiene opciones
Investing Investing
ALLO
2026.02.05
Vicepresidente de Allogene vende acciones por $63,189 y obtiene opciones
Investing Investing
ALLO
2026.02.05
Allogene EVP Roberts sells $63,189 in stock, gains options

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd